← Patent-cliff monitor small molecule EUCRISA CRISABOROLE
Loss of exclusivity July 2030 latest FDA-listed patent expiry
Drug detail Brand name EUCRISA Active ingredient CRISABOROLE Strength 2% Dosage form OINTMENT Route TOPICAL Modality Small molecule FDA approval December 2016 Marketing status RX
Listed patents Patent Expires Type 8168614*PED July 2030 — 8168614 January 2030 use U-1932 8039451*PED December 2029 — 8039451 June 2029 substance, product 9682092*PED August 2027 — 8501712*PED August 2027 — 8501712 February 2027 use U-1932 9682092 February 2027 use U-1932
Regulatory exclusivity Code Expires D-191 April 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.